+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

India Magnetic Resonance Imaging (MRI) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 88 Pages
  • August 2026
  • Region: India
  • Mordor Intelligence
  • ID: 5937668
India magnetic resonance imaging (MRI) market size in 2026 is estimated at USD 297.87 million, growing from 2025 value of USD 278.12 million with 2031 projections showing USD 419.79 million, growing at 7.10% CAGR over 2026-2031. This report is Segmented by Architecture (Closed MRI Systems, Open MRI Systems), Field Strength (Low-Field, Mid-Field, High-Field, Ultra-High Field), Application (Neurology, Musculoskeletal, Cardiovascular, Abdominal and Pelvic, Breast Imaging, and Oncology (Whole Body)), End User (Public Hospitals, Private Hospitals, and More). The Market Forecasts are Provided in Terms of Value (USD).

India Magnetic Resonance Imaging (MRI) Market Trends and Insights

Rising NCD Burden Accelerates Diagnostic Imaging Demand

India’s escalating NCD prevalence raises the clinical urgency for high-resolution soft-tissue imaging. Cancer incidence is expected to climb from 529.40 per 100,000 in 2022 to 549.17 per 100,000 by 2031, underpinning structural demand for MRI-based oncology diagnostics. Stroke, epilepsy, and neuro-degenerative conditions also continue to rise, so neurologists increasingly prescribe MRI scans for finer lesion mapping, boosting daily scanner utilization, particularly in secondary cities where care gaps remain acute. Government screening programs for breast and cervical cancer routinely direct patients toward MRI for confirmatory scans, embedding the modality into standard care pathways. Health-insurance payouts under Ayushman Bharat further raise affordability for low-income households, sustaining patient-volume growth in the India MRI market. Consequently, providers view MRI capacity expansion as a prerequisite for clinical relevance as disease patterns evolve.

Expansion of Private Diagnostic-Center Chains & Medical Tourism

Organized diagnostic networks such as Dr. Lal PathLabs, Neuberg, and Metropolis collectively operate over 1,500 imaging hubs, and the number could double by 2028 as asset-light franchise models reduce capital intensity. These groups channel fresh scanner installations into smaller cities where competition is limited, thus diffusing India MRI market penetration beyond metro clusters. In parallel, medical-tourism arrivals rose to 463,725 visas in 2024 as foreign patients sought cost-advantaged cancer, spine, and cardiac care bundled with MRI diagnostics. Hospitals in Delhi, Chennai, and Kochi advertise fixed-price oncology packages that include pre- and post-surgical 3 T MRI scans, reinforcing MRI as a revenue anchor. Such inbound traffic incentivizes providers to install premium-spec systems with AI-accelerated throughput to maintain service levels. The dual tailwind of domestic and foreign demand keeps scanner-purchase pipelines healthy for OEMs and local assemblers.

High Scanner Cost & Low Reimbursement Tariffs

Imported 1.5 T or 3 T scanners cost INR 6-9 crore (USD 730,000-1.1 million at FY 2024 exchange rates), a steep hurdle for small hospitals serving low-to-middle-income populations. Government reimbursement under Ayushman Bharat averages INR 3,000 (USD 36) per scan, barely covering electricity, helium, and maintenance. Consequently, many district-level facilities limit MRI utilization to complex cases, undercutting economies of scale and elongating ROI timelines beyond seven years. Although domestic manufacturing promises lower prices, early units still face validation delays, prolonging the affordability gap. Without tariff recalibration or bundled-payment alternatives, bottom-line pressure could temper India MRI market uptake in cost-constrained geographies.

Other drivers and restraints analyzed in the detailed report include:

  • Public-Hospital Imaging Upgrades Under Ayushman Bharat
  • AI-Enabled High-Field Imaging Boosts Throughput & Quality
  • Shortage of Trained Radiologists/Technologists

Segment Analysis

Closed systems generated 75.20% of 2025 revenue in the India Magnetic Resonance Imaging market, reflecting provider preference for higher signal-to-noise ratios essential for neuro-oncology and vascular imaging. The sealed bore design also supports gradient strengths above 45 mT/m, enabling advanced diffusion and functional protocols that smaller clinics use to attract complex referrals. High utilization levels keep per-scan costs competitive, reinforcing closed scanners as the workhorse of the India Magnetic Resonance Imaging market. Patient comfort, however, remains a pain point; claustrophobia-induced cancellations can reach 8% in urban centers, prompting providers to explore supplemental open-system capacity.

Open systems, though holding only 24.80% of 2025 value, are projected to grow at 8.05% CAGR through 2031, outpacing the overall India Magnetic Resonance Imaging market. Better patient tolerance, bariatric-friendly table loads, and pediatric volumes drive adoption, especially within suburban diagnostic chains. AI-powered image-reconstruction software narrows the historical resolution gap, letting providers conduct routine spine and MSK studies with acceptable quality. Local OEMs leverage modular coil designs to shorten installation footprints, positioning open scanners as pragmatic expansion units where real estate costs are high. As reimbursement parity between open and closed scans spreads beyond Karnataka and Maharashtra, incremental installations may accelerate, diversifying vendor portfolios and reducing the dominance of sealed-bore architectures.

1.5 T scanners captured 55.72% of the India Magnetic Resonance Imaging market size in 2025, balancing diagnostic versatility with infrastructure friendliness; they require only 600 sq ft of shielded space and standard 45 kVA power. Public hospitals favor 1.5 T for broad-spectrum applications - from trauma triage to liver volumetry - maximizing reimbursement throughput. Domestic manufacture could trim acquisition costs by 35-40%, preserving 1.5 T’s market lead through 2031. Yet academic centers seek finer gradient fidelity for research; thus, 3 T and higher systems, although currently 14% of installed base, are forecast to grow faster than the India Magnetic Resonance Imaging market at 7.72% CAGR.

Ultra-high field (7 T) remains niche because of CDSCO clearance lags and INR 40 crore (USD 4.8 million) price tags. Still, premier institutes in Delhi, Bengaluru, and Hyderabad are provisioning space for future 7 T suites, encouraged by early neuroscience grants from the Department of Biotechnology. Low-field systems (< 1.5 T) maintain marginal presence in point-of-care stroke and neonatal ICUs; Hyperfine’s 0.064 T portable unit gained marketing authorization in 2024 and can fit into ambulance bays, hinting at decentralized imaging opportunities. Taken together, field-strength segmentation underscores stratified purchasing behavior within the India Magnetic Resonance Imaging market: value-driven district hospitals gravitate toward 1.5 T, while flagship centers stretch into the ultra-high field frontier to differentiate academic output.

Complete Report Scope:

  • By Architecture
    • Closed MRI Systems
    • Open MRI Systems
  • By Field Strength
    • Low-field (Less than 0.3 T)
    • Mid-field (0.3-1.5 T)
    • High-field (3 T)
    • Ultra-high field (Above 3 T)
  • By Application
    • Neurology
    • Musculoskeletal
    • Cardiovascular
    • Abdominal & Pelvic
    • Breast Imaging
    • Oncology (Whole Body)
  • By End User
    • Public Hospitals
    • Private Hospitals
    • Diagnostic Imaging Centers
    • Ambulatory Surgical Centers

List of Companies Covered in this Report:

  • Wipro GE Healthcare Pvt Ltd
  • Siemens Healthineers
  • Philips India Ltd
  • Hitachi
  • Canon
  • Fujifilm Holdings Corp
  • United Imaging Healthcare
  • Esaote
  • Voxelgrids Innovations Pvt Ltd
  • Hyperfine Inc
  • Neusoft Medical Systems
  • IMRIS Inc
  • Medtronic plc (iMRI)
  • Allengers
  • Time Medical Systems
  • Shenzhen Anke High-Tech
  • Aspect Imaging
  • Aurora Imaging Technology
  • Bharat Electronics Ltd (MRI R&D)
  • Agfa HealthCare (NOVA MRI PACS)

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising NCD Burden (Cancer, Neuro, CVD)
4.2.2 Expansion of Private Diagnostic-Centre Chains & Medical Tourism
4.2.3 Public-Hospital Imaging Upgrades Under Ayushman Bharat
4.2.4 AI-Enabled High-Field Imaging Boosts Throughput & Quality
4.2.5 Make-In-India MRI Manufacturing Lowers Cap-Ex
4.2.6 Ban on Refurbished Imports Shifts Demand To New Units
4.3 Market Restraints
4.3.1 High Scanner Cost & Low Reimbursement Tariffs
4.3.2 Shortage of Trained Radiologists/Technologists
4.3.3 Helium Supply Volatility Elevates OPEX
4.3.4 CDSCO Approval Lags For >3 T Systems
4.4 Value Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter’s Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers/Consumers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitute Products
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Architecture
5.1.1 Closed MRI Systems
5.1.2 Open MRI Systems
5.2 By Field Strength
5.2.1 Low-field (Less than 0.3 T)
5.2.2 Mid-field (0.3-1.5 T)
5.2.3 High-field (3 T)
5.2.4 Ultra-high field (Above 3 T)
5.3 By Application
5.3.1 Neurology
5.3.2 Musculoskeletal
5.3.3 Cardiovascular
5.3.4 Abdominal & Pelvic
5.3.5 Breast Imaging
5.3.6 Oncology (Whole Body)
5.4 By End User
5.4.1 Public Hospitals
5.4.2 Private Hospitals
5.4.3 Diagnostic Imaging Centers
5.4.4 Ambulatory Surgical Centers
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Wipro GE Healthcare Pvt Ltd
6.3.2 Siemens Healthineers
6.3.3 Philips India Ltd
6.3.4 Hitachi Medical Systems
6.3.5 Canon Medical Systems
6.3.6 Fujifilm Holdings Corp
6.3.7 United Imaging Healthcare
6.3.8 Esaote SpA
6.3.9 Voxelgrids Innovations Pvt Ltd
6.3.10 Hyperfine Inc
6.3.11 Neusoft Medical Systems
6.3.12 IMRIS Inc
6.3.13 Medtronic plc (iMRI)
6.3.14 Allengers Medical Systems Ltd
6.3.15 Time Medical Systems
6.3.16 Shenzhen Anke High-Tech
6.3.17 Aspect Imaging
6.3.18 Aurora Imaging Technology
6.3.19 Bharat Electronics Ltd (MRI R&D)
6.3.20 Agfa HealthCare (NOVA MRI PACS)
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Wipro GE Healthcare Pvt Ltd
  • Siemens Healthineers
  • Philips India Ltd
  • Hitachi Medical Systems
  • Canon Medical Systems
  • Fujifilm Holdings Corp
  • United Imaging Healthcare
  • Esaote SpA
  • Voxelgrids Innovations Pvt Ltd
  • Hyperfine Inc
  • Neusoft Medical Systems
  • IMRIS Inc
  • Medtronic plc (iMRI)
  • Allengers Medical Systems Ltd
  • Time Medical Systems
  • Shenzhen Anke High-Tech
  • Aspect Imaging
  • Aurora Imaging Technology
  • Bharat Electronics Ltd (MRI R&D)
  • Agfa HealthCare (NOVA MRI PACS)